Overview
Smart money at a glance
Filings to Oct 11, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 3 cutEven
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 11- Open
- $31.05
- 52-wk high
- $36.80
- High
- $31.11
- 52-wk low
- $18.01
- Low
- $31.03
- Prev close
- $31.05
- Mkt cap
- $4.65B
- P/E
- 23.5x
- Volume
- 6.21M
- Fwd P/E
- 11.2x
- Beta
- 0.58
- P/S
- 0.8x
- P/B
- 2.8x
- Profit margin
- +3.7%
- Op margin
- +5.9%
- ROE
- +16.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about OPCH filings
Are insiders buying or selling Option Care Health Inc (OPCH) stock?
Neither. Option Care Health Inc (OPCH) insiders filed no open-market purchases or sales in the 90 days to Oct 11, 2026, according to SEC Form 4 filings.
Which members of Congress have traded OPCH recently?
None. No member of Congress disclosed a OPCH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this OPCH smart-money data?
This summary uses filings available on Oct 11, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Buys/Adds (1)
- P7

Point72
$22.6M
added
Sells/Trims (2)
- CI

Citadel
$61.0M
trimmed
- SD

Stanley Druckenmiller
$50.3M
sold
What insiders are doing
Buys (3)
- ST
Sullivan Timothy P
$500K
bought
- KH
Kraemer Harry M Jansen Jr
$784K
bought
- SM
Sethna Meenal
$327K
bought
How top traders are positioned
No tracked top-trader positions in OPCH right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings landed in line with what analysts expected.
Last report
Jul 29, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.37 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $0.37 / $0.37Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $0.40 / $0.37Alpha Vantage | +8.11% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 24, 2026 | $0.46 / $0.47Alpha Vantage | -1.20% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 30, 2025 | $0.45 / $0.43Alpha Vantage | +4.65% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 30, 2025 | $0.41 / $0.40Alpha Vantage | +2.50% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 29, 2025 | $0.40 / $0.34Alpha Vantage | +17.65% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 26, 2025 | $0.37 / $0.36Alpha Vantage | +2.01% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | $0.33 / $0.32Alpha Vantage | +3.13% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Oct 29, 2026, in 18 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.44B | $1.47B | $1.35B | $1.44B |
| Cost of what it sold | $1.18B | $1.20B | $1.10B | $1.18B |
| Gross profit | $256.6M | $263.6M | $247.1M | $267.3M |
| What it spent | ||||
| Sales and admin | $172.1M | $172.1M | $174.6M | $164.7M |
| Other operating costs | — | — | -$4.6M | $17.4M |
| Total operating expenses | $172.1M | $172.1M | $170.0M | $182.1M |
| What was left | ||||
| Operating profit | $84.5M | $91.5M | $77.2M | $85.1M |
| Interest on debt | $16.4M | $14.7M | $13.3M | $14.0M |
| Profit before tax | $69.0M | $81.5M | $61.0M | $74.0M |
| Tax | $17.2M | $23.0M | $15.7M | $20.1M |
| Net profit | $51.8M | $58.5M | $45.3M | $53.9M |
| EBITDA | $102.4M | $116.6M | $90.0M | $106.4M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace